Daver, N., Zeidner, J. F., Yuda, J., Watts, J. M., Levis, M. J., Fukushima, K., Ikezoe, T., Ogawa, Y., Brandwein, J., Wang, E. S., Miyazaki, Y., Pardee, T., Hosono, N., Shima, T., Yokoyama, H., Asada, N., Jurcic, J., Cai, H., Watanabe, A., … Erba, H. P. (2023). Phase 1/2 First-in-Human Study of the Menin-MLL Inhibitor DSP-5336 in Patients with Relapsed or Refractory Acute Leukemia. Blood, 142(Supplement 1), 2911–2911. https://doi.org/10.1182/blood-2023-179252
Subjects:
Targeted Protein Degradation in Biomedical Research
(OpenAlex Topic)
Acute Myeloid Leukemia
(OpenAlex Topic)
Ubiquitin-Proteasome Proteolytic Pathway
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1182/blood-2023-179252
Journal:
Publication Date:
Data Source:
OpenAlex
Source Link: